TY - JOUR
T1 - Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations
AU - Saruwatari, Koichi
AU - Ikemura, Shinnosuke
AU - Sekihara, Keigo
AU - Kuwata, Takeshi
AU - Fujii, Satoshi
AU - Umemura, Shigeki
AU - Kirita, Keisuke
AU - Matsumoto, Shingo
AU - Yoh, Kiyotaka
AU - Niho, Seiji
AU - Ohmatsu, Hironobu
AU - Ochiai, Atsushi
AU - Kohrogi, Hirotsugu
AU - Tsuboi, Masahiro
AU - Goto, Koichi
AU - Ishii, Genichiro
N1 - Funding Information:
This work was supported by the National Cancer Center Research and Development Fund (23-A-16).
Publisher Copyright:
© 2015 Elsevier Ireland Ltd.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Introduction: Tumor microenvironment critically affects cancer progression. This study aimed to identify differences in microenvironments of lung adenocarcinomas with epidermal growth factor receptor (EGFR) mutations by histological subtypes. Methods: The study cohort included 214 lung adenocarcinomas harboring EGFR mutations. We analyzed clinicopathological characteristics of lepidic (LPA), papillary (PPA), acinar (APA), and solid-predominant adenocarcinoma (SPA) subtypes, and examined expression levels of EGFR, E-cadherin, ezrin, laminin-5, ALDH1, and PD-L1 in cancer cells, and of CD34, CD204, podoplanin (PDPN), and FoxP3 in stromal cells in 4 subtypes (n = 20 each). Results: SPA displayed significantly more frequent lymph node metastasis, lymphovascular invasion, and worse prognosis than the other subtypes. Ezrin expression levels in SPA were also significantly higher than in LPA, PPA, or APA (P< 0.05, all). Laminin-5 and PD-L1 expression levels in SPA were significantly higher than in LPA (P< 0.01 for both) and PPA (P< 0.01 for both) and tended to be higher than in APA (laminin-5: P = 0.096, PD-L1: P = 0.081). Furthermore, SPA displayed higher levels of PDPN (+) cancer-associated fibroblasts (P< 0.01) and CD204 (+) tumor-associated macrophages (P< 0.05) than the other subtypes. Conclusion: Compared with other predominant subtypes with EGFR mutations, the microenvironment of SPA with EGFR mutations is characterized by cancer cells with higher invasive and immune evasion potential and more abundant stromal cells with tumor-promoting functions, which would contribute to the more aggressive behavior of SPA.
AB - Introduction: Tumor microenvironment critically affects cancer progression. This study aimed to identify differences in microenvironments of lung adenocarcinomas with epidermal growth factor receptor (EGFR) mutations by histological subtypes. Methods: The study cohort included 214 lung adenocarcinomas harboring EGFR mutations. We analyzed clinicopathological characteristics of lepidic (LPA), papillary (PPA), acinar (APA), and solid-predominant adenocarcinoma (SPA) subtypes, and examined expression levels of EGFR, E-cadherin, ezrin, laminin-5, ALDH1, and PD-L1 in cancer cells, and of CD34, CD204, podoplanin (PDPN), and FoxP3 in stromal cells in 4 subtypes (n = 20 each). Results: SPA displayed significantly more frequent lymph node metastasis, lymphovascular invasion, and worse prognosis than the other subtypes. Ezrin expression levels in SPA were also significantly higher than in LPA, PPA, or APA (P< 0.05, all). Laminin-5 and PD-L1 expression levels in SPA were significantly higher than in LPA (P< 0.01 for both) and PPA (P< 0.01 for both) and tended to be higher than in APA (laminin-5: P = 0.096, PD-L1: P = 0.081). Furthermore, SPA displayed higher levels of PDPN (+) cancer-associated fibroblasts (P< 0.01) and CD204 (+) tumor-associated macrophages (P< 0.05) than the other subtypes. Conclusion: Compared with other predominant subtypes with EGFR mutations, the microenvironment of SPA with EGFR mutations is characterized by cancer cells with higher invasive and immune evasion potential and more abundant stromal cells with tumor-promoting functions, which would contribute to the more aggressive behavior of SPA.
KW - Cancer cells
KW - Immunohistochemical staining
KW - Lung adenocarcinoma with EGFR mutation
KW - Microenvironment
KW - Solid predominant adenocarcinoma
KW - Stromal cells
UR - http://www.scopus.com/inward/record.url?scp=84955110032&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84955110032&partnerID=8YFLogxK
U2 - 10.1016/j.lungcan.2015.11.012
DO - 10.1016/j.lungcan.2015.11.012
M3 - Article
C2 - 26711928
AN - SCOPUS:84955110032
SN - 0169-5002
VL - 91
SP - 7
EP - 14
JO - Lung Cancer
JF - Lung Cancer
ER -